Stroke and coronary heart disease: Predictive power of standard risk factors into old age - Long-term cumulative risk study among men in Gothenburg, Sweden

European Heart Journal

Volumn 34, Issue 14, 2013, Pages 1068-1074

  Giang, Kok Wai ^a   Björck, Lena ^a   Novak, Masuma ^a   Lappas, Georgios ^a   Wilhelmsen, Lars ^a   Torén, Kjell ^a   Rosengren, Annika ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

CHD; Risk factors; Risk prediction; Score models; Stroke

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY HEIGHT; BODY WEIGHT; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; FOLLOW UP; HEART INFARCTION; HIGH RISK POPULATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PREDICTIVE VALUE; PRIMARY PREVENTION; PRIORITY JOURNAL; RISK ASSESSMENT; SMOKING; SYSTOLIC BLOOD PRESSURE;

CORONARY DISEASE; EPIDEMIOLOGIC METHODS; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; SMOKING; STROKE; SWEDEN; TIME FACTORS;

EID: 84876218590     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehs458     Document Type: Article

References (36)

1. Strong K, Mathers C, Bonita R. Preventing stroke: saving lives around the world. Lancet Neurol 2007;6:182-187.
2. Hobbs FD, Jukema JW, Da Silva PM, McCormack T, Catapano AL. Barriers to cardiovascular disease risk scoring and primary prevention in Europe. QJM 2010;103: 727-739.
3. Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G, De Bacquer D, Ducimetiere P, Jousilahti P, Keil U, Njolstad I, Oganov RG, Thomsen T, Tunstall-Pedoe H, Tverdal A, Wedel H, Whincup P, Wilhelmsen L, Graham IM. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003;24:987-1003.
4. Anderson KM, Wilson PW, Odell PM, Kannel WB. An updated coronary risk profile. A statement for health professionals. Circulation 1991;83:356-362.
5. D'Agostino RB, Wolf PA, Belanger AJ, Kannel WB. Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study. Stroke 1994;25:40-43.
6. Chen RL, Balami JS, Esiri MM, Chen LK, Buchan AM. Ischemic stroke in the elderly: an overview of evidence. Nat Rev Neurol 2010;6:256-265.
7. Wilhelmsen L, Berglund G, Elmfeldt D, Tibblin G, Wedel H, Pennert K, Vedin A, Wilhelmsson C, Werko L. The multifactor primary prevention trial in Goteborg, Sweden. Eur Heart J 1986;7:279-288.
8. Elmfeldt D, Wilhelmsen L, Tibblin G, Vedin JA, Wilhelmsson CE, Bengtsson C. Registration of myocardial infarction in the city of Goteborg, Sweden. J Chronic Dis 1975;28:173-186.
9. Harmsen P, Tibblin G. A stroke register in Goteborg, Sweden. Acta Med Scand 1972;191:463-470.
10. Jason PF, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. JASA 1999;94:496-509.
11. Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988;16:1141-1154.
12. Gray B. Subdistribution analysis of competing risks. R package Version 2.2-2 2011.
13. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360:1903-1913.
14. Franklin SS, Larson MG, Khan SA, Wong ND, Leip EP, Kannel WB, Levy D. Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study. Circulation 2001;103:1245-1249.
15. Kannel WB, Gordon T, Schwartz MJ. Systolic versus diastolic blood pressure and risk of coronary heart disease. The Framingham study. Am J Cardiol 1971;27: 335-346.
16. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004;364:937-952.
17. O'Donnell MJ, Xavier D, Liu L, Zhang H, Chin SL, Rao-Melacini P, Rangarajan S, Islam S, Pais P, McQueen MJ, Mondo C, Damasceno A, Lopez-Jaramillo P, Hankey GJ, Dans AL, Yusoff K, Truelsen T, Diener HC, Sacco RL, Ryglewicz D, Czlonkowska A, Weimar C, Wang X, Yusuf S. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet 2010;376:112-123.
18. Yano K, Reed DM, MacLean CJ. Serum cholesterol and hemorrhagic stroke in the Honolulu Heart Program. Stroke 1989;20:1460-1465.
19. Suzuki K, Izumi M, Sakamoto T, Hayashi M. Blood pressure and total cholesterol level are critical risks especially for hemorrhagic stroke in Akita, Japan. Cerebrovasc Dis 2011;31:100-106.
20. Qizilbash N, Lewington S, Duffy S, Peto R. Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts. Prospective studies collaboration. Lancet 1995;346:1647-1653.
21. Endres M, Heuschmann PU, Laufs U, Hakim AM. Primary prevention of stroke: blood pressure, lipids, and heart failure. Eur Heart J 2011;32:545-552.
22. Lewington S, Whitlock G, Clarke R, Sherliker P, Emberson J, Halsey J, Qizilbash N, Peto R, Collins R. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet 2007;370:1829-1839.
23. Boysen G, Nyboe J, Appleyard M, Sorensen PS, Boas J, Somnier F, Jensen G, Schnohr P. Stroke incidence and risk factors for stroke in Copenhagen, Denmark. Stroke 1988;19:1345-1353.
24. Bonita R, Duncan J, Truelsen T, Jackson RT, Beaglehole R. Passive smoking as well as active smoking increases the risk of acute stroke. Tob Control 1999;8:156-160.
25. Harmsen P, Lappas G, Rosengren A, Wilhelmsen L. Long-term risk factors for stroke: twenty-eight years of follow-up of 7457 middle-aged men in Goteborg, Sweden. Stroke 2006;37:1663-1667.
26. Wilhelmsen L. ESC population studies lecture 1996. Cardiovascular monitoring of a city over 30 years. Eur Heart J 1997;18:1220-1230.
27. Wilhelmsen L, Lappas G, Rosengren A. Risk of coronary events by baseline factors during 28 years follow-up and three periods in a random population sample of men. J Intern Med 2004;256:298-307.
28. Wilhelmsen L, Berglund G, Werko L. Prevalence and management of hypertension in a general population sample of Swedish men. Prev Med 1973;2:57-66.
29. Boe J, Humerfelt S,Wedervang F. The blood pressure in a population; blood pressure readings and height and weight determinations in the adult population of the city of Bergen. Acta Med Scand Suppl 1957;321:1-336.
30. Kagan A, Gordon T, Kannel W, Dawber T. Blood pressure and its relation to coronary heart disease in the Framingham Study. Hypertension 7 1959;4:53-81.
31. Wilhelmsen L. Treatment of hypertension in a Swedish community - the problem of borderline hypertension. Acta Med Scand 1975;197(S576):99-108.
32. Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense HW, Joffres M, Kastarinen M, Poulter N, Primatesta P, Rodriguez-Artalejo F, Stegmayr B, Thamm M, Tuomilehto J, Vanuzzo D, Vescio F. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 2003;289:2363-2369.
33. Vartiainen E, Laatikainen T, Peltonen M, Juolevi A, Mannisto S, Sundvall J, Jousilahti P, Salomaa V, Valsta L, Puska P. Thirty-five-year trends in cardiovascular risk factors in Finland. Int J Epidemiol 2010;39:504-518.
34. Bjorck L, Rosengren A, Bennett K, Lappas G, Capewell S. Modelling the decreasing coronary heart disease mortality in Sweden between 1986 and 2002. Eur Heart J 2009;30:1046-1056.
35. Leren P, Askevold E, Foss O, Froili A, Grymyr D, Helgeland A, Hjermann I, Holme I, Lund-Larsen P, Norum K. The Oslo Study, Cardiovascular disease in middle-aged and young Oslo men. Acta Med Scand 1975;588(Suppl):1-38.
36. Capewell S, Ford ES. Why have total cholesterol levels declined in most developed countries?. BMC Public Health 2011;11:641.